BractonDeal Intel
Get full access
AcquisitionOther

ADIAL PHARMACEUTICALS, INC. acquired target

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

ADIAL PHARMACEUTICALS, INC. -> target

2 to the Purchase Agreement (the "Purchase Agreement Amendment") with certain PIPE Investors, constituting holders of the Majority of Interest (as defined in the Purchase Agreement), pursuant to which the Purchase Agreement was amended to (i) remove the Penalt

Open source record (SEC) ↗
Bracton Partners

Sell-side M&A advisory for software, fintech and data companies. Everything on these pages is built from primary sources: SEC filings, company announcements, and the public record. No estimates and no unnamed sources.

bractonpartners.comApproachForm D monitorDisclosures

M&A advisory only. No capital-raising services are offered. Nothing on this page is a valuation, a recommendation, or an offer of any security.